1)Higby DJ, Wallace HJ Jr, Albert DJ, et al:Diaminodichloroplatinum:a phase I study showing responses in testicular and other tumors. Cancer 33:1219-1215, 1974
2)Einhorn LH and Donohue J:Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
3)CISPLATIN Clinical experience overview
4)Williams SD, Birch R, Einhorn LH, et al:Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
5)Mead GM, Russell M, Clark P, et al:A randomized trial comparing methotrexate and vinblastine(MV)with cisplatin, methotrexate and vinblastine(CMV)in advanced transitional cell carcinoma:results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party. Br J Cancer 78:1067-1075, 1998
6)Loehrer PJ Sr, Einhorn LH, Elson PJ, et al:A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma:a cooperative group study. J Clin Oncol 10:1066-1073, 1992
7)Huggins C:Effect of orchiectomy and irradiation on cancer of the prostate. Ann Surg 115:1192-1200, 1942
8)Bailar JC 3rd and Byar DP:Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer 26:257-261, 1970
9)[No authors listed]:Leuprolide versus diethylstilbestrol for metastatic prostate cancer. The Leuprolide Study Group. N Engl J Med 311:1281-1286, 1984
10)Pyrhonen S, Salminen E, Ruutu M, et al:Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol 17:2859-2867, 1999
11)[No authors listed]:Interferon-alpha and survival in metastatic renal carcinoma:early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet 353:14-17, 1999
12)Flanigan RC, Salmon SE, Blumenstein BA, et al:Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655-1659, 2001
13)Mickisch GH, Garin A, van Poppel H, et al:Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma:a randomised trial. Lancet 358:966-970, 2001